Anzeige
Mehr »
Dienstag, 20.01.2026 - Börsentäglich über 12.000 News
98,7% Goldausbeute ohne Cyanid - kommt jetzt der Milliarden-Deal?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LA7D | ISIN: CA65337X1042 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXGENRX INC Chart 1 Jahr
5-Tage-Chart
NEXGENRX INC 5-Tage-Chart

Aktuelle News zur NEXGENRX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.12.25NexgenRx Inc: NexgenRx to pay 0.5-cent dividend Dec. 191
11.12.25Nexgenrx declares CAD 0.005 dividend1
11.12.25NexgenRx Inc.: NexgenRx Announces Declaration of Divdends363TORONTO, ON / ACCESS Newswire / December 10, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been...
► Artikel lesen
21.11.25Market-beating micro-cap NexgenRX excels in Q31
21.11.25Nexgenrx reports Q3 results1
21.11.25NexgenRx Inc.: NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth356TORONTO, ON / ACCESS Newswire / November 20, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the third quarter ended September 30, 2025, with quarterly...
► Artikel lesen
19.08.25NexgenRx Inc: NexgenRx to pay 0.5-cent dividend Aug. 293
15.08.25NexgenRx declares CAD 0.005 dividend1
NEXGENRX Aktie jetzt für 0€ handeln
15.08.25NexgenRx Inc.: NexgenRx Announces Declaration of Dividend408TORONTO, ON / ACCESS Newswire / August 15, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been...
► Artikel lesen
13.08.25Nexgenrx reports Q2 results1
13.08.25NexgenRx Inc: NexgenRx's Q2 2025 revenue at $349,0431
13.08.25NexgenRx Inc.: NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA451TORONTO, ON / ACCESS Newswire / August 12, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2025, with quarterly...
► Artikel lesen
15.05.25NexgenRx, Inc.: NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA374TORONTO, ON / ACCESS Newswire / May 15, 2025 / NEXGENRX INC. (TSX.V:NXG) ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2025, with quarterly...
► Artikel lesen
17.04.25NexgenRx Inc.: NexgenRx Announces Declaration of Divdend453TORONTO, ON / ACCESS Newswire / April 17, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been...
► Artikel lesen
04.04.25NexgenRx, Inc.: NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA502TORONTO, ON / ACCESS Newswire / April 3, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2024, with continued...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1